Quick Summary

Polyporus umbellatus is an edible fungus traditionally used to promote water metabolism and address water balance disorders. Its main bioactive compounds are polysaccharides, which have been studied for potential nutritional and medicinal effects. While preclinical research has investigated its preparation, chemical makeup, and possible applications, robust clinical evidence in humans remains limited and inconclusive. Ongoing studies explore its potential roles in managing kidney stones (urolithiasis), metabolic diseases, adjunctive cancer therapy, and immune system modulation; however, direct clinical efficacy and safety data specific to Polyporus umbellatus are scarce.

What is it

Polyporus umbellatus is a type of mushroom commonly used in traditional Chinese medicine. It is known for its distinctive umbrella-like fruiting body and is classified as an edible fungus. This herb has been historically valued for its effects on fluid regulation in the body.

Traditional Uses

Traditionally, Polyporus umbellatus has been used to support water metabolism and to treat disorders related to water retention. It has been incorporated into herbal formulas aimed at promoting healthy urinary function and maintaining fluid balance.

Active Compounds

The key bioactive components of Polyporus umbellatus are polysaccharides. These complex carbohydrates are thought to contribute to the fungus’s reported health effects, including immunomodulation and potential metabolic benefits. Research is also examining other chemical constituents, but polysaccharides remain the primary focus.

Potential Benefits with Evidence Levels

  • Urolithiasis (kidney stones): Phytotherapy involving Polyporus umbellatus is under investigation as a complementary approach alongside conventional treatments for kidney stones. However, randomized controlled trials specifically assessing Polyporus are limited, and the appropriate dosages, mechanisms, and interactions are not well understood.
    Evidence Level: Research Pending / Insufficient Human Clinical Data
  • Immune function modulation and adjunctive cancer therapy: Polysaccharides from Polyporus umbellatus have demonstrated immune-enhancing properties in preclinical studies. Chinese herbal products containing Polyporus are sometimes included in multi-herb formulas combined with chemotherapy. Nonetheless, direct evidence from high-quality trials on Polyporus alone is lacking.
    Evidence Level: Limited Clinical Evidence (mostly polyherbal formulations)
  • Metabolic dysfunction and liver diseases: Reviews suggest that traditional medicines containing Polyporus may have potential to improve metabolic and liver function outcomes. However, clinical trials focusing specifically on Polyporus polysaccharides are preliminary and inconclusive.
    Evidence Level: Preclinical and Early Clinical Evidence

Side Effects

Currently, there are no significant adverse effects specifically attributed to Polyporus umbellatus reported in clinical literature. Toxicity appears low within commonly prescribed dosages, but overall human safety data and adverse reaction reports are limited.

Drug Interactions

Data on drug interactions involving Polyporus umbellatus are insufficient. Given its inclusion in polyherbal formulas, sometimes combined with chemotherapy or other medications, potential interactions cannot be ruled out though they have not been systematically studied.

Who Should Avoid It

No explicit contraindications for Polyporus umbellatus have been established due to insufficient clinical research. However, pregnant and breastfeeding women should exercise caution and avoid use or only use under medical supervision, as safety in these populations has not been established.

Evidence Limitations

  • Lack of high-quality randomized controlled trials directly evaluating the efficacy and safety of Polyporus umbellatus in humans.
  • Most clinical data involve multi-herb formulas where Polyporus is one ingredient, limiting insights on its standalone effects.
  • Predominance of preclinical studies; clinical translation is limited and preliminary.
  • Available studies often have small sample sizes and methodological limitations.
  • No standardized preparations, dosages, or quality control parameters for Polyporus extracts have been established.
  • Limited information on pharmacokinetics, pharmacodynamics, and drug interaction profiles.
  • Insufficient safety data for vulnerable groups, including pregnant and breastfeeding women.

References

  • Mutomba WF et al. (2025). Phytotherapy in Urolithiasis: An Updated Overview of Current Knowledge. Europe PMC. https://europepmc.org/articles/PMC12072574. DOI: 10.3390/jcm14092885
  • Gao W et al. (2025). A systematic review of advances in preparation, structures, bioactivities, structural-property relationships, and applications of Polyporus umbellatus polysaccharides. Europe PMC. https://europepmc.org/articles/PMC11780138. DOI: 10.1016/j.fochx.2025.102161
  • Lo CYZ et al. (2025). Systematic review of pharmacological, complementary, and alternative therapies for the prevention of calcium oxalate stones. Europe PMC. https://europepmc.org/articles/PMC12126926. DOI: 10.1016/j.ajur.2024.04.006
  • Shen M et al. (2024). Traditional Chinese herbal medicine: harnessing dendritic cells for anti-tumor benefits. Europe PMC. https://europepmc.org/articles/PMC11446781. DOI: 10.3389/fimmu.2024.1408474

Last Reviewed

April 2025

Disclaimer: This information is for educational purposes and does not constitute medical advice. Consult a qualified healthcare professional before using Polyporus umbellatus or any herbal supplement, especially if you are pregnant, breastfeeding, have a medical condition, or are taking other medications.